STOCK TITAN

AdvanSix Announces Third Quarter 2024 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

AdvanSix (ASIX) reported strong Q3 2024 financial results with sales of $398 million, up 23% year-over-year. Net Income reached $22.3 million, with Adjusted EBITDA of $53.2 million and margin of 13.4%. The company saw an 11% increase in volume, 8% higher raw material pass-through pricing, and 5% favorable market-based pricing. Cash Flow from Operations improved to $57.3 million. The company was awarded a $12 million USDA grant for granular ammonium sulfate expansion. However, the company expects an approximately $17 million unfavorable impact to pre-tax income in Q4 2024 due to maintenance issues and delayed operations at the Hopewell site.

AdvanSix (ASIX) ha riportato forti risultati finanziari nel Q3 2024, con vendite di $398 milioni, in aumento del 23% rispetto all'anno precedente. Il reddito netto ha raggiunto $22,3 milioni, con un EBITDA rettificato di $53,2 milioni e un margine del 13,4%. L'azienda ha registrato un aumento del 11% nel volume, un incremento dell'8% nei prezzi di pass-through delle materie prime e un 5% di prezzi favorevoli basati sul mercato. Il flusso di cassa dalle operazioni è migliorato a $57,3 milioni. L'azienda ha ricevuto un contributo USDA di $12 milioni per l'espansione del solfato di ammonio granulare. Tuttavia, l'azienda prevede un impatto negativo di circa $17 milioni sul reddito ante imposte nel Q4 2024 a causa di problemi di manutenzione e operazioni ritardate presso il sito di Hopewell.

AdvanSix (ASIX) reportó resultados financieros sólidos para el tercer trimestre de 2024, con ventas de $398 millones, un incremento del 23% en comparación con el año anterior. La renta neta alcanzó $22,3 millones, con un EBITDA ajustado de $53,2 millones y un margen del 13,4%. La compañía observó un aumento del 11% en el volumen, un incremento del 8% en los precios de materiales crudos y un 5% en precios favorables basados en el mercado. El flujo de efectivo de las operaciones mejoró a $57,3 millones. La empresa recibió una para la expansión de sulfato de amonio granular. Sin embargo, la empresa espera un impacto negativo de aproximadamente $17 millones en los ingresos antes de impuestos en el cuarto trimestre de 2024 debido a problemas de mantenimiento y operaciones retrasadas en el sitio de Hopewell.

AdvanSix (ASIX)는 2024년 3분기 재무 결과가 강력하다고 보고했으며, 매출은 $398 백만으로 전년 대비 23% 증가했습니다. 순이익은 $22.3 백만에 달했으며, 조정된 EBITDA는 $53.2 백만이고, 마진은 13.4%입니다. 회사는 물량이 11% 증가하고, 원자재 가격통과가 8% 상승하며, 시장 기반 가격이 5% 호조를 보였습니다. 운영으로 인한 현금 흐름은 $57.3 백만으로 개선되었습니다. 회사는 과립 황산암모늄 확장을 위한 $12 백만 USDA 보조금을 받았습니다. 그러나 회사는 Hopewell 사이트의 유지 보수 문제와 지연된 운영으로 인해 2024년 4분기 세전 소득에 약 $17 백만의 부정적인 영향을 예상하고 있습니다.

AdvanSix (ASIX) a annoncé de solides résultats financiers pour le troisième trimestre 2024, avec des ventes atteignant 398 millions $, en hausse de 23 % par rapport à l'année précédente. Le revenu net a atteint 22,3 millions $, avec un EBITDA ajusté de 53,2 millions $ et une marge de 13,4 %. L'entreprise a constaté une augmentation de 11 % du volume, une hausse de 8 % des prix des matières premières et une amélioration de 5 % des prix sur le marché. Le flux de trésorerie provenant des opérations a été amélioré à 57,3 millions $. L'entreprise a reçu une aide de 12 millions $ de l'USDA pour l'expansion du sulfate d'ammonium granulé. Cependant, l'entreprise prévoit un impact négatif d'environ 17 millions $ sur le revenu avant impôts au quatrième trimestre 2024 en raison de problèmes de maintenance et de retards d'exploitation sur le site de Hopewell.

AdvanSix (ASIX) hat starke Finanzergebnisse für das dritte Quartal 2024 gemeldet, mit einem Umsatz von 398 Millionen $, was einem Anstieg von 23 % im Vergleich zum Vorjahr entspricht. Der Nettogewinn betrug 22,3 Millionen $, mit einem bereinigten EBITDA von 53,2 Millionen $ und einer Marge von 13,4 %. Das Unternehmen verzeichnete einen Anstieg des Volumens um 11 %, einen Anstieg der Rohstoffpreisdurchreichung um 8 % und einen Anstieg der marktgerechten Preise um 5 %. Der Cashflow aus der betrieblichen Tätigkeit verbesserte sich auf 57,3 Millionen $. Das Unternehmen erhielt einen USDA-Zuschuss in Höhe von 12 Millionen $ für die Expansion von granulierter Ammoniumsulfat. Allerdings erwartet das Unternehmen einen etwa 17 Millionen $ ungünstigen Einfluss auf das Ergebnis vor Steuern im vierten Quartal 2024 aufgrund von Wartungsproblemen und verzögerten Arbeiten am Standort Hopewell.

Positive
  • Sales increased 23% year-over-year to $398 million
  • Net Income improved by $30.2 million to $22.3 million
  • Adjusted EBITDA increased by $45.8 million to $53.2 million
  • Cash Flow from Operations grew by $36.4 million to $57.3 million
  • Secured $12 million USDA grant for capacity expansion
Negative
  • Expected $17 million negative impact to Q4 2024 pre-tax income due to operational issues
  • $10 million additional costs from fixed cost absorption and maintenance
  • $7 million in lost sales projected due to delayed operations at Hopewell site

Insights

Strong quarterly performance with substantial improvements across key metrics. $398M in sales represents a 23% YoY growth, driven by volume increases and favorable pricing. Notable is the $53.2M Adjusted EBITDA, a significant improvement from $7.3M last year, with margins expanding to 13.4%.

The operational challenges at the Hopewell facility will impact Q4 with an expected $17M hit to pre-tax income, though the company has returned to targeted utilization rates. The USDA grant of $12M for capacity expansion strengthens their growth trajectory in premium grade products.

Strong cash flow generation with $57.3M from operations shows improved working capital management. The maintained quarterly dividend of $0.16 per share reflects financial stability despite operational headwinds.

Market conditions are notably favorable across key segments. The ammonium sulfate segment shows robust demand driven by agricultural sulfur nutrition needs, while acetone markets display constructive supply-demand dynamics. The North American nylon industry is showing modest improvement, suggesting a potential upward trend in industry spreads.

Portfolio diversification is proving effective with chemical intermediates comprising 30% of sales, followed by ammonium sulfate at 27%, nylon at 24% and caprolactam at 19%. This balanced revenue mix provides stability and multiple growth avenues, particularly as the company expands premium grade production capacity.

Sales of $398 million, up 23% versus prior year

Earnings Per Share of $0.82; Adjusted Earnings Per Share of $0.88

Cash Flow from Operations of $57 million, up $36 million versus prior year

Awarded $12 million grant from USDA to support expansion of granular ammonium sulfate

Appointed Sidd Manjeshwar as SVP and CFO, effective October 1

PARSIPPANY, N.J.--(BUSINESS WIRE)-- AdvanSix (NYSE: ASIX), a diversified chemistry company, today announced its financial results for the third quarter ending September 30, 2024. Overall, the Company delivered strong sales, earnings and cash flow performance while continuing to invest for long-term sustainable growth.

Third Quarter 2024 Summary

  • Sales up approximately 23% versus prior year driven by an approximately 11% increase in volume, 8% higher raw material pass-through pricing, and 5% favorable impact of market-based pricing
  • Net Income of $22.3 million, an increase of $30.2 million versus the prior year
  • Adjusted EBITDA of $53.2 million, an increase of $45.8 million versus the prior year
  • Adjusted EBITDA Margin of 13.4%, up 1,110 bps versus the prior year
  • Cash Flow from Operations of $57.3 million, an increase of $36.4 million versus the prior year
  • Capital Expenditures of $30.5 million, an increase of $5.4 million versus the prior year
  • Free Cash Flow of $26.8 million, an increase of $31.1 million versus the prior year

“In the third quarter, AdvanSix capitalized on the strength of our competitive position to deliver robust results with the continued realization of commercial performance across our diverse product portfolio and strong operational execution,” said Erin Kane, president and CEO of AdvanSix. “The AdvanSix team drove top and bottom-line growth as well as continued cash flow improvement amid a strong ammonium sulfate fall fill program supporting higher pricing year-over-year, a constructive global acetone supply and demand environment, and modestly improving North American nylon industry conditions. We are accelerating focused growth in the most profitable areas of our business and were pleased to be awarded an approximately $12 million grant from the U.S. Department of Agriculture to increase our production capacity of premium grade products, reinforcing a strong return profile for our SUSTAIN (Sustainable U.S. Sulfate to Accelerate Increased Nutrition) program.”

Summary third quarter 2024 financial results for the Company are included below:

($ in Thousands, Except Earnings Per Share)

 

3Q 2024

 

3Q 2023

Sales

 

$398,187

 

$322,907

Net Income (Loss)

 

22,266

 

(7,977)

Diluted Earnings Per Share

 

$0.82

 

($0.29)

Adjusted Diluted Earnings Per Share (1)

 

$0.88

 

($0.36)

Adjusted EBITDA (1)

 

53,161

 

7,321

Adjusted EBITDA Margin % (1)

 

13.4%

 

2.3%

Cash Flow from Operations

 

57,250

 

20,802

Free Cash Flow (1)(2)

 

26,760

 

(4,329)

(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations

(2) Net cash provided by operating activities less capital expenditures

Sales of $398 million in the quarter increased approximately 23% versus the prior year. Sales volume increased approximately 11% primarily driven by higher sales of ammonium sulfate supported by sulfur nutrition demand. Raw material pass-through pricing was favorable by 8% as a result of a net cost increase in benzene and propylene (inputs to cumene which is a key feedstock to our products). Market-based pricing was favorable by 5% including continued strength in acetone, as well as ammonium sulfate as growers seeking to maximize crop yields continue to recognize the benefits of sulfur nutrition.

Sales by product line and approximate percentage of total sales are included below:

($ in Thousands)

 

3Q 2024

 

3Q 2023 (1)

 

 

Sales

 

% of Total

 

Sales

 

% of Total

Nylon

 

$

93,693

 

24%

 

$

86,056

 

27%

Caprolactam

 

 

76,338

 

19%

 

 

68,795

 

21%

Ammonium Sulfate

 

 

107,668

 

27%

 

 

79,067

 

24%

Chemical Intermediates

 

 

120,488

 

30%

 

 

88,989

 

28%

Total

 

$

398,187

 

100%

 

$

322,907

 

100%

(1) Previously reported amounts have been updated for a reclassification of certain products representing approximately $5.5 million of sales in 3Q 2023 between Ammonium Sulfate (decreased) and Chemical Intermediates (increased). Total sales were not impacted.

Adjusted EBITDA of $53.2 million in the quarter increased $45.8 million versus the prior year primarily driven by favorable pricing, net of raw material costs, higher sales volume, and the timing of planned plant turnarounds.

Adjusted earnings per share of $0.88 increased $1.24 versus the prior year driven primarily by the factors discussed above.

Cash flow from operations of $57.3 million in the quarter increased $36.4 million versus the prior year primarily driven by higher net income. Capital expenditures of $30.5 million in the quarter increased $5.4 million versus the prior year primarily reflecting planned increased spend on maintenance and enterprise programs.

Outlook

  • Ammonium sulfate order book sold through 4Q24 amid continued strong sulfur nutrition demand
  • Expect balanced to tight global acetone supply and demand conditions
  • Expect North American nylon industry spreads to modestly improve amid stable end market demand
  • Expect Capital Expenditures to now be $135 to $140 million in 2024, reflecting refined execution timing to address critical enterprise risk mitigation and growth projects including our SUSTAIN (Sustainable U.S. Sulfate to Accelerate Increased Nutrition) program
  • As a result of additional required maintenance and a delayed ramp to full operating rates at our Hopewell site following our planned plant turnaround, we expect an incremental approximately $17 million unfavorable impact to pre-tax income in 4Q24, inclusive of $10 million related to fixed cost absorption and higher maintenance expense, and $7 million of lost sales; no impact on 3Q24 results

Manufacturing plant turnarounds are a critical enabler for driving operational excellence, safety and compliance across the AdvanSix enterprise, and key to achieving and sustaining disproportionately higher operating rates given our competitive cost advantage. This year’s fourth quarter planned turnaround was comprehensive in scope, designed to encompass maintenance and reliability work at our three major sites. The mechanical portion of the turnaround was safely and well executed across all sites, however we experienced a delayed ramp to full operating rates in our Hopewell facility given a challenge associated with our Ammonia plant re-start.

“2024 has truly been a year of contrasts. On the positive side, we have consistently demonstrated our agility and focus by deploying the right strategies and actions to achieve commercial success while advancing targeted growth initiatives. On the opportunity side, while we have proven ability to navigate and recover from operational difficulties, our manufacturing execution this year has not met our expectations. Operational excellence is a key enabler to our overall performance, with meaningful performance upside for us to capture, and we take all learnings for sustained continuous improvement with rigor and discipline. Despite the unfavorable impact of the extended turnaround in the fourth quarter, we are pleased to have returned to our targeted utilization rates and our outlook for the remainder of the year and 2025 continues to be supported by our diverse product portfolio, advantaged business model and favorable industry dynamics. We remain confident in the growth prospects for AdvanSix, and are committed to delivering sustainable long-term value to our shareholders,” concluded Kane.

Dividend

The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. The dividend is payable on November 26, 2024 to stockholders of record as of the close of business on November 12, 2024.

Conference Call Information

AdvanSix will discuss its results during its investor conference call today starting at 9:00 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:00 a.m. ET start, and tell the operator that you are dialing in for AdvanSix’s third quarter 2024 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on November 1 until 12 noon ET on November 8 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 2537780.

About AdvanSix

AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people’s lives. Our integrated value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates. More information on AdvanSix can be found at http://www.advansix.com.

Forward Looking Statements

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of political and policy uncertainties with the approaching U.S. Presidential election, and the conflict between Russia and Ukraine, the conflict in Israel and Gaza, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics and geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023, as updated in subsequent reports filed with the SEC.

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

AdvanSix Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(Dollars in thousands, except share and per share amounts)

   

 

 

September 30, 2024

 

December 31, 2023

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

17,298

 

 

$

29,768

 

Accounts and other receivables – net

 

 

149,058

 

 

 

165,393

 

Inventories – net

 

 

213,434

 

 

 

211,831

 

Taxes receivable

 

 

375

 

 

 

1,434

 

Other current assets

 

 

15,608

 

 

 

11,378

 

Total current assets

 

 

395,773

 

 

 

419,804

 

 

 

 

 

 

Property, plant and equipment – net

 

 

892,574

 

 

 

852,642

 

Operating lease right-of-use assets

 

 

90,740

 

 

 

95,805

 

Goodwill

 

 

56,192

 

 

 

56,192

 

Intangible assets

 

 

43,906

 

 

 

46,193

 

Other assets

 

 

31,050

 

 

 

25,384

 

Total assets

 

$

1,510,235

 

 

$

1,496,020

 

 

 

 

 

 

LIABILITIES

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

207,272

 

 

$

259,068

 

Accrued liabilities

 

 

55,783

 

 

 

44,086

 

Income taxes payable

 

 

435

 

 

 

8,033

 

Operating lease liabilities – short-term

 

 

30,135

 

 

 

32,053

 

Deferred income and customer advances

 

 

1,517

 

 

 

15,678

 

Total current liabilities

 

 

295,142

 

 

 

358,918

 

 

 

 

 

 

Deferred income taxes

 

 

154,690

 

 

 

151,059

 

Operating lease liabilities – long-term

 

 

60,793

 

 

 

63,961

 

Line of credit – long-term

 

 

215,000

 

 

 

170,000

 

Postretirement benefit obligations

 

 

7,048

 

 

 

3,660

 

Other liabilities

 

 

11,154

 

 

 

9,185

 

Total liabilities

 

 

743,827

 

 

 

756,783

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

 

Common stock, par value $0.01; 200,000,000 shares authorized; 32,982,868 shares issued and 26,730,739 outstanding at September 30, 2024; 32,598,946 shares issued and 26,750,471 outstanding at December 31, 2023

 

 

330

 

 

 

326

 

Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2024 and December 31, 2023

 

 

 

 

 

 

Treasury stock at par (6,252,129 shares at September 30, 2024; 5,848,475 shares at December 31, 2023)

 

 

(63

)

 

 

(58

)

Additional paid-in capital

 

 

134,735

 

 

 

138,046

 

Retained earnings

 

 

635,609

 

 

 

605,067

 

Accumulated other comprehensive loss

 

 

(4,203

)

 

 

(4,144

)

Total stockholders' equity

 

 

766,408

 

 

 

739,237

 

Total liabilities and stockholders' equity

 

$

1,510,235

 

 

$

1,496,020

 

AdvanSix Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(Dollars in thousands, except share and per share amounts)

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2024

 

2023

 

2024

 

2023

Sales

 

$

398,187

 

$

322,907

 

 

$

1,188,495

 

$

1,151,391

 

 

 

 

 

 

 

 

 

 

Costs, expenses and other:

 

 

 

 

 

 

 

 

Costs of goods sold

 

 

340,885

 

 

314,785

 

 

 

1,046,860

 

 

1,004,844

 

Selling, general and administrative expenses

 

 

24,265

 

 

21,585

 

 

 

72,290

 

 

70,711

 

Interest expense, net

 

 

2,924

 

 

2,075

 

 

 

9,137

 

 

5,296

 

Other non-operating (income) expense, net

 

 

368

 

 

(5,485

)

 

 

1,808

 

 

(6,918

)

Total costs, expenses and other

 

 

368,442

 

 

332,960

 

 

 

1,130,095

 

 

1,073,933

 

 

 

 

 

 

 

 

 

 

Income (loss) before taxes

 

 

29,745

 

 

(10,053

)

 

 

58,400

 

 

77,458

 

Income tax expense (benefit)

 

 

7,479

 

 

(2,076

)

 

 

14,603

 

 

17,753

 

Net income (loss)

 

$

22,266

 

$

(7,977

)

 

$

43,797

 

$

59,705

 

 

 

 

 

 

 

 

 

 

Earnings per common share

 

 

 

 

 

 

 

 

Basic

 

$

0.83

 

$

(0.29

)

 

$

1.63

 

$

2.18

 

Diluted

 

$

0.82

 

$

(0.29

)

 

$

1.61

 

$

2.12

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

Basic

 

 

26,790,752

 

 

27,209,521

 

 

 

26,836,114

 

 

27,433,851

 

Diluted

 

 

27,204,714

 

 

27,209,521

 

 

 

27,209,680

 

 

28,193,721

 

AdvanSix Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(Dollars in thousands)

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2024

 

2023

 

2024

 

2023

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income (loss)

 

$

22,266

 

 

$

(7,977

)

 

$

43,797

 

 

$

59,705

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

18,933

 

 

 

18,379

 

 

 

57,197

 

 

 

54,337

 

Loss on disposal of assets

 

 

154

 

 

 

371

 

 

 

415

 

 

 

939

 

Deferred income taxes

 

 

2,887

 

 

 

(2,825

)

 

 

3,638

 

 

 

1,069

 

Stock-based compensation

 

 

1,559

 

 

 

1,391

 

 

 

5,963

 

 

 

5,840

 

Amortization of deferred financing fees

 

 

155

 

 

 

155

 

 

 

464

 

 

 

464

 

Operational asset adjustments

 

 

 

 

 

(4,472

)

 

 

1,200

 

 

 

(4,472

)

Changes in assets and liabilities, net of business acquisitions:

 

 

 

 

 

 

 

 

Accounts and other receivables

 

 

21,073

 

 

 

20,062

 

 

 

15,069

 

 

 

42,185

 

Inventories

 

 

(37,607

)

 

 

(3,598

)

 

 

(1,603

)

 

 

(14,082

)

Taxes receivable

 

 

(196

)

 

 

(56

)

 

 

1,059

 

 

 

8,273

 

Accounts payable

 

 

17,994

 

 

 

(4,245

)

 

 

(43,687

)

 

 

(50,123

)

Income taxes payable

 

 

(572

)

 

 

3,474

 

 

 

(7,598

)

 

 

2,136

 

Accrued liabilities

 

 

4,839

 

 

 

(2,043

)

 

 

10,988

 

 

 

(7,787

)

Deferred income and customer advances

 

 

369

 

 

 

82

 

 

 

(14,161

)

 

 

(32,015

)

Other assets and liabilities

 

 

5,396

 

 

 

2,104

 

 

 

(1,493

)

 

 

(9,088

)

Net cash provided by operating activities

 

 

57,250

 

 

 

20,802

 

 

 

71,248

 

 

 

57,381

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Expenditures for property, plant and equipment

 

 

(30,490

)

 

 

(25,131

)

 

 

(99,373

)

 

 

(69,025

)

Other investing activities

 

 

(2,317

)

 

 

(370

)

 

 

(6,053

)

 

 

(2,404

)

Net cash used for investing activities

 

 

(32,807

)

 

 

(25,501

)

 

 

(105,426

)

 

 

(71,429

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Borrowings from line of credit

 

 

54,000

 

 

 

140,500

 

 

 

311,500

 

 

 

371,000

 

Payments of line of credit

 

 

(69,000

)

 

 

(110,500

)

 

 

(266,500

)

 

 

(316,000

)

Principal payments of finance leases

 

 

(260

)

 

 

(242

)

 

 

(762

)

 

 

(698

)

Dividend payments

 

 

(4,276

)

 

 

(4,350

)

 

 

(12,858

)

 

 

(12,354

)

Purchase of treasury stock

 

 

(42

)

 

 

(9,266

)

 

 

(10,427

)

 

 

(37,651

)

Issuance of common stock

 

 

328

 

 

 

131

 

 

 

755

 

 

 

876

 

Net cash provided by (used for) financing activities

 

 

(19,250

)

 

 

16,273

 

 

 

21,708

 

 

 

5,173

 

 

 

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

 

5,193

 

 

 

11,574

 

 

 

(12,470

)

 

 

(8,875

)

Cash and cash equivalents at beginning of period

 

 

12,105

 

 

 

10,536

 

 

 

29,768

 

 

 

30,985

 

Cash and cash equivalents at the end of period

 

$

17,298

 

 

$

22,110

 

 

$

17,298

 

 

$

22,110

 

 

 

 

 

 

 

 

 

 

Supplemental non-cash investing activities:

 

 

 

 

 

 

 

 

Capital expenditures included in accounts payable

 

 

 

 

 

$

15,018

 

 

$

21,188

 

AdvanSix Inc.

Non-GAAP Measures

(Dollars in thousands, except share and per share amounts)

 

Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

   

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2024

 

2023

 

2024

 

2023

Net cash provided by operating activities

 

$

57,250

 

 

$

20,802

 

 

$

71,248

 

 

$

57,381

 

Expenditures for property, plant and equipment

 

 

(30,490

)

 

 

(25,131

)

 

 

(99,373

)

 

 

(69,025

)

Free cash flow (1)

 

$

26,760

 

 

$

(4,329

)

 

$

(28,125

)

 

$

(11,644

)

 

 

 

 

 

 

 

 

 

(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment

 

The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

   

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2024

 

2023

 

2024

 

2023

Net income (loss)

 

$

22,266

 

 

$

(7,977

)

 

$

43,797

 

 

$

59,705

 

Non-cash stock-based compensation

 

 

1,559

 

 

 

1,391

 

 

 

5,963

 

 

 

5,840

 

Non-recurring, unusual or extraordinary (income) expense (2)

 

 

 

 

 

(4,472

)

 

 

1,200

 

 

 

(4,472

)

Non-cash amortization from acquisitions

 

 

531

 

 

 

532

 

 

 

1,595

 

 

 

1,596

 

Non-recurring M&A costs

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (benefit) relating to reconciling items

 

 

(367

)

 

 

776

 

 

 

(1,594

)

 

 

(157

)

Adjusted Net income (loss) (non-GAAP)

 

 

23,989

 

 

 

(9,750

)

 

 

50,961

 

 

 

62,512

 

Interest expense, net

 

 

2,924

 

 

 

2,075

 

 

 

9,137

 

 

 

5,296

 

Income tax expense (benefit) - Adjusted

 

 

7,846

 

 

 

(2,852

)

 

 

16,197

 

 

 

17,911

 

Depreciation and amortization - Adjusted

 

 

18,402

 

 

 

17,848

 

 

 

55,602

 

 

 

52,741

 

Adjusted EBITDA (non-GAAP)

 

$

53,161

 

 

$

7,321

 

 

$

131,897

 

 

$

138,460

 

 

 

 

 

 

 

 

 

 

Sales

 

$

398,187

 

 

$

322,907

 

 

$

1,188,495

 

 

$

1,151,391

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA Margin (non-GAAP) (3)

 

 

13.4

%

 

 

2.3

%

 

 

11.1

%

 

 

12.0

%

 

 

 

 

 

 

 

 

 

(2) 2024 includes a pre-tax loss of approximately $1.2 million from the reduction of the Company’s anticipated receivable related to the gain on the termination fee recorded upon the exit from the Oben Holding Group S.A. alliance during the third quarter of 2023. During 2023, there were several transactions including the exit from the Oben Holding Group S.A. alliance, licensee exit of legacy technology and exit of certain low-margin oximes products that resulted in a $4.5 million net pre-tax loss.

(3) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2024

 

2023

 

2024

 

2023

Net income (loss)

 

$

22,266

 

$

(7,977

)

 

$

43,797

 

$

59,705

Adjusted Net income (loss) (non-GAAP)

 

 

23,989

 

 

(9,750

)

 

 

50,961

 

 

62,512

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding - basic

 

 

26,790,752

 

 

27,209,521

 

 

 

26,836,114

 

 

27,433,851

Dilutive effect of equity awards and other stock-based holdings

 

 

413,962

 

 

 

 

 

373,566

 

 

759,870

Weighted-average number of common shares outstanding - diluted

 

 

27,204,714

 

 

27,209,521

 

 

 

27,209,680

 

 

28,193,721

 

 

 

 

 

 

 

 

 

EPS - Basic

 

$

0.83

 

$

(0.29

)

 

$

1.63

 

$

2.18

EPS - Diluted

 

$

0.82

 

$

(0.29

)

 

$

1.61

 

$

2.12

Adjusted EPS - Basic (non-GAAP)

 

$

0.90

 

$

(0.36

)

 

$

1.90

 

$

2.28

Adjusted EPS - Diluted (non-GAAP)

 

$

0.88

 

$

(0.36

)

 

$

1.87

 

$

2.22

   

The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.

AdvanSix Inc.

Appendix

(Pre-tax income impact, Dollars in millions)

 

Planned Plant Turnaround Schedule (4)

             

 

 

1Q

 

2Q

 

3Q

 

4Q

 

FY

 

Primary Unit Operation

2017

 

 

~$10

 

~$4

 

~$20

 

~$34

 

Sulfuric Acid

2018

 

~$2

 

~$10

 

~$30

 

 

~$42

 

Ammonia

2019

 

 

~$5

 

~$5

 

~$25

 

~$35

 

Sulfuric Acid

2020

 

~$2

 

~$7

 

~$20

 

~$2

 

~$31

 

Ammonia

2021

 

~$3

 

~$8

 

 

~$18

 

~$29

 

Sulfuric Acid

2022

 

~$1

 

~$5

 

~$44(5)

 

 

~$50

 

Ammonia

2023

 

~$2

 

~$1

 

~$27

 

 

~$30

 

Sulfuric Acid

2024E

 

~$5

 

~$3

 

~$3

 

~$47(6)

 

~$58

 

Ammonia

             

(4) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

(5) During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our Hopewell and Chesterfield sites, resulting in an incremental $15 million unfavorable impact to pre-tax income inclusive of fixed cost absorption, higher maintenance expense and lost sales.

(6) During the multi-site planned plant turnaround, additional required maintenance at our Hopewell plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates, resulting in an incremental approximately $17 million unfavorable impact to pre-tax income inclusive of fixed cost absorption, higher maintenance expense, and lost sales

 

Media

Janeen Lawlor

(973) 526-1615

janeen.lawlor@advansix.com

Investors

Adam Kressel

(973) 526-1700

adam.kressel@advansix.com

Source: AdvanSix

FAQ

What was AdvanSix (ASIX) revenue in Q3 2024?

AdvanSix reported sales of $398.2 million in Q3 2024, representing a 23% increase compared to the same period last year.

How much was AdvanSix (ASIX) Q3 2024 earnings per share?

AdvanSix reported diluted earnings per share of $0.82 and adjusted earnings per share of $0.88 in Q3 2024.

What is the impact of Hopewell site issues on AdvanSix (ASIX) Q4 2024?

AdvanSix expects a $17 million unfavorable impact to pre-tax income in Q4 2024, including $10 million in fixed cost absorption and maintenance expenses, and $7 million in lost sales.

What is the Q3 2024 dividend announced by AdvanSix (ASIX)?

AdvanSix declared a quarterly cash dividend of $0.16 per share, payable on November 26, 2024, to stockholders of record as of November 12, 2024.

AdvanSix Inc.

NYSE:ASIX

ASIX Rankings

ASIX Latest News

ASIX Stock Data

843.90M
25.86M
3.25%
89.87%
0.97%
Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States of America
PARSIPPANY